NCT05890092

Brief Summary

Vulvar disease in Nigeria A look at awareness within patients and health practitioners, self-reported and actual prevalence within communities in Nigeria

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started May 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
May 2023Nov 2026

Study Start

First participant enrolled

May 3, 2023

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

May 25, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 6, 2023

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2026

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Expected
Last Updated

June 6, 2023

Status Verified

May 1, 2023

Enrollment Period

3 years

First QC Date

May 25, 2023

Last Update Submit

May 25, 2023

Conditions

Vulvar DiseasesVulvar AtrophyDermatoses

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Vulvar disease

    Awareness of Vulvar disease (descriptor)

    1-12 months

Interventions

ObservationOTHER

Observing for disease prevalence - actual and self-reported

Eligibility Criteria

Age10 Years - 90 Years
Sexfemale
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All afab, willing to participate in the study.

You may qualify if:

  • biological females - afab

You may not qualify if:

  • none-afab

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kdrs

London, Rm166el, United Kingdom

RECRUITING

MeSH Terms

Conditions

Vulvar DiseasesSkin Diseases

Interventions

Observation

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2023

First Posted

June 6, 2023

Study Start

May 3, 2023

Primary Completion

May 2, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

June 6, 2023

Record last verified: 2023-05

Locations

GB(1)